Legal Representation
Attorney
Karen Won
USPTO Deadlines
Application History
40 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 8, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jun 5, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jun 6, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 6, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 6, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Dec 5, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Dec 5, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 11, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 12, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jun 12, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jun 11, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 12, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 10, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Dec 10, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 10, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 3, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 3, 2023 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Jun 2, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 5, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 2, 2023 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| May 5, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| May 30, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 5, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| May 5, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 20, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 25, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 25, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 5, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 20, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 20, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 20, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 20, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 20, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 19, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 19, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 19, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 14, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 10, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 9, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and biologic preparations for use in oncology, immunology, and cell degeneration; Pharmaceutical preparations, namely, therapeutic agents, immunotherapies, antibody therapies, and cell therapies for the treatment of cancer, autoimmune diseases, degenerative diseases; Vaccines; Antibodies for medical and medical diagnostic laboratory use
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"